2022 BSR指南：应用生物以及靶向合成DMARDs治疗银屑病关节炎
发布日期：
2022-05-31
英文标题：
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
出处：
Rheumatology (Oxford).2022 May 31;
摘要：
2022年5月，英国风湿病学会(BSR)发布了应用生物以及靶向合成DMARDs治疗银屑病关节炎指南。银屑病关节炎（PsA）是一种慢性炎症性肌肉骨骼疾病，本文是对2012年版PsA指南的更新。主要针对PsA治疗中的生物以及靶向合成DMARDs的应用提供指导建议。
展开部分内容仅可在
临床指南app 查看下载
阅读免费指南
发送到邮箱
收藏
分享
评论
提交评论
/ 没有更多了 /
上传者信息
香芋
于2022-06-02上传
编者信息
英国风湿病学会
BSR promotes excellence in the treatment of people with arthritis and musculoskeletal conditions and supports those delivering it. We have over 25 years of expertise in promoting high quality standards of care, providing education, training and support to those working in rheumatology. We have more than 1,500 members including rheumatologists, scientists, trainees, allied health professionals and others from the UK and overseas.
置顶
